Literature DB >> 952270

Aneurysm of the atrial septum in tricuspid atresia: diagnosis during life and therapy.

R M Freedom, R D Rowe.   

Abstract

Massive aneurysmal dilatation of the foramen ovale was diagnosed angiocardiographically in a patient with tricuspid atresia. The angiographic findings are distinct for this condition, and the pathogenesis appears to be related to a restrictive atrial communication in the patient with obligatory right to left shunting at atrial level. The anatomic potential for atrial restriction in the patient with tricuspid or pulmonary atresia, intact ventricular septum and diminutive right ventricle necessitates balloon atrial septostomy at the initial diagnostic cardiac catheterization. In the patient with aneurysmal dilatation of the foramen ovale, satisfactory decompression may be achieved by Blalock-Hanlon atrial septectomy, open atrial septectomy, or, possibly, balloon septostomy.

Entities:  

Mesh:

Year:  1976        PMID: 952270     DOI: 10.1016/0002-9149(76)90161-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Diagnostic value of transesophageal echocardiography in atrial septal aneurysm.

Authors:  B Schneider; T Hofmann; T Meinertz; P Hanrath
Journal:  Int J Card Imaging       Date:  1992

2.  Aneurysm of the fossa ovalis in infants: a pathologic study.

Authors:  O Topaz; A Feigl; J E Edwards
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

3.  Atrial septal aneurysm--a potential cause of systemic embolism. An echocardiographic study.

Authors:  B Gallet; M C Malergue; C Adams; J P Saudemont; A M Collot; M C Druon; M Hiltgen
Journal:  Br Heart J       Date:  1985-03

4.  True congenital aneurysm of the septum primum not associated with obstructive right- or left-sided lesions: identified by two-dimensional echocardiography and angiography in a newborn.

Authors:  A Casta; D Casta; D W Sapire; L Swischuk
Journal:  Pediatr Cardiol       Date:  1983 Apr-Jun       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.